Hexagon Nutrition IPO is a Book Built Issue aggregating up to ₹138.87 crore. The entire issue comprises an Offer for Sale (OFS) of 3,08,59,704 equity shares by existing shareholders. Since the issue is entirely an OFS, the company will not receive any proceeds from the IPO.
Hexagon Nutrition Limited is a research-driven nutrition company engaged in developing and manufacturing micronutrient premixes, branded wellness products, clinical nutrition formulations, therapeutic nutrition solutions, and ready-to-use foods.
| IPO Open Date | June 5, 2026 |
|---|---|
| IPO Close Date | June 9, 2026 |
| Issue Type | Book Built Issue |
| Issue Size | ₹138.87 Crore |
| Offer for Sale | 3,08,59,704 Equity Shares |
| Face Value | ₹1 per Share |
| Price Band | ₹42 - ₹45 per Share |
| Lot Size | 333 Shares |
| Listing Exchange | BSE & NSE |
| Listing Date | June 12, 2026 (Tentative) |
| Market Capitalization (Pre-IPO) | ₹553.13 Crore |
Incorporated in 1993, Hexagon Nutrition Limited is a research-focused nutrition company engaged in developing, manufacturing and marketing nutrition products across wellness, clinical nutrition, therapeutic nutrition and micronutrient fortification categories.
The company operates three manufacturing facilities in India located at Nashik (Maharashtra), Chennai (Tamil Nadu) and Thoothukudi (Tamil Nadu), along with an overseas manufacturing facility in Tashkent, Uzbekistan. The Chennai and Thoothukudi facilities are located within Special Economic Zones (SEZs), offering logistical and operational advantages.
Hexagon Nutrition serves both domestic and international markets through a diversified portfolio spanning consumer nutrition, healthcare nutrition and public health nutrition solutions.
The company has built a PAN-India omnichannel distribution network covering retail pharmacies, hospitals, e-commerce marketplaces, online pharmacies and direct-to-consumer platforms. As of March 2026, Hexagon Nutrition worked with more than 358 distributors across India, including several multi-state distributors.
The company has established overseas offices in South Africa, Uzbekistan and Hong Kong and exported products to over 75 countries across Asia, Africa, Europe and South America during Fiscal 2023 to Fiscal 2025.
Hexagon Nutrition maintains dedicated in-house R&D facilities at Nashik and Chennai. Its research team consists of qualified professionals focused on product innovation, nutritional science and formulation development.
As of March 31, 2026, the company employed 527 people.
| Location | State/Country | Facility Type |
|---|---|---|
| Nashik | Maharashtra, India | Manufacturing Facility |
| Chennai | Tamil Nadu, India | SEZ Manufacturing Facility |
| Thoothukudi | Tamil Nadu, India | SEZ Manufacturing Facility |
| Tashkent | Uzbekistan | International Manufacturing Facility |
| Application Category | Lots | Shares | Investment Amount (₹) |
|---|---|---|---|
| Retail Minimum | 1 | 333 | 14,985 |
| sNII Minimum | 14 | 4,662 | 2,09,790 |
| bNII Minimum | 67 | 22,311 | 10,03,995 |
| Event | Date |
|---|---|
| IPO Opens | June 5, 2026 |
| IPO Closes | June 9, 2026 |
| Basis of Allotment | June 10, 2026 |
| Initiation of Refunds | June 11, 2026 |
| Credit of Shares | June 11, 2026 |
| Listing Date | June 12, 2026 |
Refer to RHP for detailed Information.
The IPO is entirely an Offer for Sale by existing shareholders. Accordingly, the company will not receive any proceeds from the issue. The selling shareholders will receive the net proceeds after deducting applicable expenses and taxes.
Kfin Technologies Limited is the registrar to the issue and will manage allotment, refunds and investor-related services.
Cumulative Capital Private Limited and Catalyst Capital Partners Private Limited are the Book Running Lead Managers to the issue.
Registrar: KFin Technologies Limited
Empower your IPO investment journey — stay informed with accurate dates, price band and filings.
Track Live & Upcoming IPOs
Hexagon Nutrition IPO will open on June 5, 2026 and close on June 9, 2026.
The IPO price band has been fixed at ₹42 to ₹45 per equity share.
The minimum application size is 333 shares, requiring an investment of ₹14,985 at the upper price band.
No. The IPO is entirely an Offer for Sale (OFS) of 3,08,59,704 equity shares by existing shareholders.
The shares are proposed to be listed on BSE and NSE on June 12, 2026.
Kfin Technologies Limited is the registrar to the issue.
Cumulative Capital Private Limited and Catalyst Capital Partners Private Limited are the Book Running Lead Managers to the issue.
Hexagon Nutrition Limited is a nutrition-focused company engaged in manufacturing and marketing clinical nutrition products, wellness supplements, micronutrient premixes, therapeutic formulations, ready-to-use foods and public health nutrition products.
The company exported its products to more than 75 countries across Asia, Africa, Europe and South America during Fiscal 2023 to Fiscal 2025.
Disclaimer: - Investments in securities market are subject to market risk, read all the related document carefully before investing. https://www.mnclgroup.com/research-disclaimer
Empower your finances with ReSach – the stock trading apptrusted by serious investors. Whether you're planning to invest in stocks, explore commodity trading, or need a financial advisor to guide you, Resach brings it all under one platform.
Start trading today with ReSach and unlock seamless investing on the go.
Name of the Company has changed from Networth Stock Broking Limited to Monarch Networth Capital Limited upon Certification of Incorporation received from Registrar of Companies, Mumbai vide certificate dated 13th October, 2015.
If you are not satisfied with the resolution provided, you can lodge your complaint online at: https://scores.sebi.gov.in/link
In case of grievance client can log on to the SMART ODR Portal, if they are unsatisfied with the response provided by us. Your attention is drawn to the SEBI circular no. SEBI/HO/OIAE/OIAE_IAD-1/P/CIR/2023/131 dated July 31, 2023, on “Online Resolution of Disputes in the Indian Securities Market”.
Purchase of REs only gives buyer the right to participate in the ongoing Rights Issue of the concerned company by making an application with requisite application money or renounce the REs before the issue closes. REs which are neither subscribed by making an application with requisite application money nor renounced, on or before the Issue closing date shall lapse and shall be extinguished after the Issue closing date. Please check your dp account for further details.
Please do not share your online trading password with anyone as this could weaken the security of your account and lead to unauthorized trades or losses.
Monarch Networth Capital Limited (‘MNCL’) | CIN No.: L64990GJ1993PLC120014
Unit No. 803-804A, 8th Floor, X-Change Plaza, Block No. 53, Zone 5, Road-5E, Gift City, Gandhinagar - 382050, Gujarat
Ahmedabad
“Monarch House”, Opp Prahladbhai Patel garden, Near Ishwar Bhuvan, Commerce Six Roads, Navrangpura, Ahmedabad - 380009
Mumbai
Monarch Networth Capital Limited, G Block, Laxmi Tower, B Wing, 4th Floor, Bandra Kurla Complex, Bandra East, Mumbai - 400051.
Email for Grievance: grievances@mnclgroup.com
Investors are requested to note that Stock broker (Monarch Networth Capital Ltd) is permitted to receive money from investors through designated bank accounts only named as Up streaming Client Nodal Bank Account (USCNBA). Stock broker (Monarch Networth Capital Ltd) is also required to disclose these USCNB accounts to Stock Exchange. Hence, you are requested to use following USCNB accounts only (Click to View) for the purpose of dealings in your trading account with us. The details of these USCNB accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker".
Mechanism for addressing grievances and information about SCORES.
Monarch Networth Capital IFSC Private Limited (Wholly owned subsidiary of Monarch Networth Capital Limited) is a Registered Fund Management Entity (Retail) having Registration No: IFSCA/FME/III/2025-26/169. Monarch India Growth Fund will be an open-ended Restricted Scheme (Non-Retail) construed as a Category III AIF under the IFSCA (Fund Management) Regulations, 2025. Monarch AIF is a Category III AIF having SEBI Registration No. IN/AIF3/20-21/0787. This material is for informational purposes only and is not intended as an offer or solicitation or investment advice to buy or sell securities. Investments are subject to market risks. The offering is made only through official scheme documents to eligible investors under GIFT IFSC regulations. Investors should read all documents carefully and consult their advisors before investing.
Mechanism for addressing grievances and information about SCORES.
Monarch Networth Capital Limited (‘MNCL’) | CIN No.: L64990GJ1993PLC120014
(As per LODR Regulations and Companies Act, 2013)
Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances : Mr. Nitesh Tanwar : 022 - 66476400 / 66476405
Monarch Networth Capital Limited
Unit No. 803-804A, 8th Floor, X-Change Plaza, Block No. 53, Zone 5, Road-5E, Gift City, Gandhinagar - 382050, Gujarat
Ahmedabad
“Monarch House”, Opp Prahladbhai Patel garden, Near Ishwar Bhuvan, Commerce Six Roads, Navrangpura, Ahmedabad – 380009
Mumbai
Monarch Networth Capital Limited, G Block, Laxmi Tower, B Wing, 4th Floor, Bandra Kurla Complex, Bandra East, Mumbai - 400051.
For Broking and Demat Related Queries : +91-79-26666768
Email: cs@mnclgroup.com
Email for Grievance: cs@mnclgroup.com
Listing of Equity Shares on Stock Exchange at
BSE
NSE
(Formerly known as Link Intime India Private Limited)
For any queries related to broking please contact helpdesk@mnclgroup.com.
‘Investments in securities market are subject to market risks, read all the related documents carefully before investing.’
